{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:59:07Z","timestamp":1764194347896,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,1,24]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>We present a patient with Crohn\u2019s disease under treatment with adalimumab who developed acute myeloid leukaemia (AML) with core-binding factor beta gene rearrangement. This case report emphasises the importance of long-term close follow-up of patients receiving adalimumab because of the increased risk of developing AML and other malignancies.<\/jats:p>","DOI":"10.1136\/bcr-2018-225680","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T04:19:10Z","timestamp":1549253950000},"page":"bcr-2018-225680","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Adalimumab-induced acute myeloid leukaemia in a patient with Crohn\u2019s disease"],"prefix":"10.1136","volume":"12","author":[{"given":"Talal","family":"Alzahrani","sequence":"first","affiliation":[{"name":"Department of Medicine, The George Washington University, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulelah","family":"Nuqali","sequence":"additional","affiliation":[{"name":"Department of Medicine, The George Washington University, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejat","family":"Naser","sequence":"additional","affiliation":[{"name":"Department of Medicine, The George Washington University, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar R","family":"Jariwala","sequence":"additional","affiliation":[{"name":"Department of Pathology, The George Washington University, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,2,3]]},"reference":[{"key":"2025082722474231000_12.2.bcr-2018-225680.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.07.002"},{"key":"2025082722474231000_12.2.bcr-2018-225680.2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0016-5085(75)80270-8","article-title":"Clinical patterns in Crohn\u2019s disease: a statistical study of 615 cases","volume":"68","author":"Farmer","year":"1975","journal-title":"Gastroenterology"},{"key":"2025082722474231000_12.2.bcr-2018-225680.3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0016-5085(79)90389-5","article-title":"Clinical features and natural history of Crohn\u2019s disease","volume":"77","author":"Mekhjian","year":"1979","journal-title":"Gastroenterology"},{"key":"2025082722474231000_12.2.bcr-2018-225680.4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.168"},{"key":"2025082722474231000_12.2.bcr-2018-225680.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00159"},{"key":"2025082722474231000_12.2.bcr-2018-225680.6","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s10067-015-3026-7","article-title":"Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study","volume":"34","author":"Berghen","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2025082722474231000_12.2.bcr-2018-225680.7","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-014-0449-5","article-title":"The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study","volume":"16","author":"Wu","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025082722474231000_12.2.bcr-2018-225680.8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/jdv.12675","article-title":"An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors","volume":"29","author":"van L\u00fcmig","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025082722474231000_12.2.bcr-2018-225680.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg128"},{"key":"2025082722474231000_12.2.bcr-2018-225680.10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00002018-200831050-00013","article-title":"TNF-alpha inhibitors and leukaemia: international pharmacovigilance reports","volume":"31","author":"Meyboom","year":"2008","journal-title":"Drug Saf"},{"key":"2025082722474231000_12.2.bcr-2018-225680.11","unstructured":"FDA alert. Tumor necrosis factor (TNF) blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi). http:\/\/www.fda.gov\/Drugs\/DrugSafety\/Postmarket Drug Safety Information for Patients and Providers\/Drug Safety Information for Heathcare Professionals\/ucm174474.htm"},{"key":"2025082722474231000_12.2.bcr-2018-225680.12","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21005"},{"key":"2025082722474231000_12.2.bcr-2018-225680.13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.056283"},{"key":"2025082722474231000_12.2.bcr-2018-225680.14","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e318188950a"},{"key":"2025082722474231000_12.2.bcr-2018-225680.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(01)02064-5"},{"key":"2025082722474231000_12.2.bcr-2018-225680.16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208024"},{"key":"2025082722474231000_12.2.bcr-2018-225680.17","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.cgh.2014.08.025","article-title":"Risk of myeloid neoplasms in inflammatory bowel disease patients is linked to exposure to thiopurines and not with tumor necrosis factor-alpha inhibitors","volume":"13","author":"Deepak","year":"2015","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-225680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:47:52Z","timestamp":1756360072000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-225680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,3]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bcr-2018-225680"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-225680","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}